Cohance Lifesciences News and Activities

Presence

Cohance Lifesciences develops and manufactures pharmaceutical ingredients, specialty chemicals, and related services for drug companies and healthcare customers. It supports research, development, and commercial supply across regulated and emerging markets.

Cohance Lifesciences products and services overview:

Active ingredients
Specialty chemicals
Custom synthesis
CDMO services
Process development
Analytical services

Revenue: ~$160 million

Employees: 1,800

Headquarters: Hyderabad, India

Cohance Lifesciences is owned by Advent International.

Advent International is one of the...

Advent International has a direct presence in 21 countries.

Advent International has 41 subsidiaries including Addiko Bank, Addiko Bank Bosnia And Herzegovina and Addiko Croatia.

They are in:

Food19%
Banking17%
Other64%

Acquisition, funding and merger involving Advent International.

Advent International has announced the acquisition of Salt & Stone (posted on March 25 2026).
Advent International has acquired Automic Group (posted on March 18 2026).
Advent International has acquired TBI Bank (posted on March 3 2026).
Advent International has acquired Sapiens (posted on December 19 2025).
Advent International has announced the acquisition of Sapiens (posted on August 16 2025).
Syspro and Advent International have announced they will merge (posted on August 15 2024)..
See more news about Advent International Hide news involving Advent International

Executives

View the org chart displaying its 26 main executives

Most searched biographies at Cohance Lifesciences

Popular executive movements at Cohance Lifesciences

Umang Vohra will join the company as Executive Chairman of the Board on May 1, 2026 (posted on April 28 2026).
Gunjan Singh, who was Business Head, API and Formulations, is promoted to Chief Executive Officer, API Plus Business (posted on November 17 2025).
Ravinath Shetty has joined the company as Chief Operating Officer, Platform (posted on November 11 2025).

Click here to view some more movements at Cohance Lifesciences

Create your alert
to follow the executive moves at Cohance Lifesciences.